PAM
MIRM icon

Panagora Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Panagora Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5M Buy
337,461
+208,347
+161% +$20.9M 0.12% 163
2026
Q1 		$11.9M Buy
+129,114
New +$12.1M 0.04% 302
2023
Q1 		– Sell
-21,270
Closed -$415K – 1501
2022
Q4 		$415K Sell
21,270
-53,762
-72% -$1.06M ﹤0.01% 1209
2022
Q3 		$1.58M Buy
75,032
+551
+0.7% +$13.3K 0.01% 683
2022
Q2 		$1.45M Buy
74,481
+4,995
+7% +$118K 0.01% 737
2022
Q1 		$1.53M Buy
69,486
+2,427
+4% +$49.5K 0.01% 763
2021
Q4 		$1.07M Buy
67,059
+39
+0.1% +$607 0.01% 888
2021
Q3 		$1.33M Buy
67,020
+9,268
+16% +$151K 0.01% 840
2021
Q2 		$999K Sell
57,752
-141
-0.2% -$2.53K 0.01% 987
2021
Q1 		$1.15M Buy
57,893
+36,724
+173% +$703K 0.01% 960
2020
Q4 		$370K Buy
+21,169
New +$416K ﹤0.01% 1347

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's MIRM Position: Q2 2026 in Review

Panagora Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 161% in Q2 2026, buying an estimated $20.9M and bringing the position to 337,461 shares worth $39.5M. The position accounts for 0.12% of the portfolio, ranked #163.

Panagora Asset Management first reported a position in MIRM in Q4 2020 and has held it in 11 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Panagora Asset Management held 337,461 shares of Mirum Pharmaceuticals worth $39.5M as of Q2 2026.
  • Panagora Asset Management bought 208,347 Mirum Pharmaceuticals shares in Q2 2026, an estimated $20.9M.
  • Mirum Pharmaceuticals made up 0.12% of Panagora Asset Management's portfolio in Q2 2026, its #163 holding.
  • Panagora Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2020 and has held it in 11 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.